Evidence map›Paper›PMID 28729539›Full record

ArticleScientific reports2017

Comparative proteomic analysis of human embryonic stem cell-derived and primary human retinal pigment epithelium.

Heidi Hongisto, Antti Jylhä, Janika Nättinen, Jochen Rieck, Tanja Ilmarinen, Zoltán Veréb, Ulla Aapola, Roger Beuerman, Goran Petrovski, Hannu Uusitalo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Clic6 Deficiency Triggers Aberrant Apical Microvilli in RPE.Investigative ophthalmology & visual science · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Heidi HongistoBioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. heidi.m.hongisto@staff.uta.fi.
Antti JylhäDepartment of Ophthalmology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Janika NättinenBioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Jochen RieckBioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Tanja IlmarinenBioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Zoltán VerébStem Cells and Eye Research Laboratory, Department of Ophthalmology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Ulla AapolaDepartment of Ophthalmology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Roger BeuermanDepartment of Ophthalmology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Goran PetrovskiStem Cells and Eye Research Laboratory, Department of Ophthalmology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Hannu UusitaloDepartment of Ophthalmology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Heli SkottmanBioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Tampere University · FITampere University · FIUniversity of Szeged · HUSingapore Eye Research Institute · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human embryonic stem cell-derived retinal pigment epithelial cells (hESC-RPE) provide an unlimited cell source for retinal cell replacement therapies. Clinical trials using hESC-RPE to treat diseases such as age-related macular degeneration (AMD) are currently underway. Human ESC-RPE cells have been thoroughly characterized at the gene level but their protein expression profile has not been studied at larger scale. In this study, proteomic analysis was used to compare hESC-RPE cells differentiated from two independent hESC lines, to primary human RPE (hRPE) using Isobaric tags for relative quantitation (iTRAQ). 1041 common proteins were present in both hESC-RPE cells and native hRPE with majority of the proteins similarly regulated. The hESC-RPE proteome reflected that of normal hRPE with a large number of metabolic, mitochondrial, cytoskeletal, and transport proteins expressed. No signs of increased stress, apoptosis, immune response, proliferation, or retinal degeneration related changes were noted in hESC-RPE, while important RPE specific proteins involved in key RPE functions such as visual cycle and phagocytosis, could be detected in the hESC-RPE. Overall, the results indicated that the proteome of the hESC-RPE cells closely resembled that of their native counterparts.

Indexed as

ProteomeProteomicsCell DifferentiationComputational BiologyGene OntologyHuman Embryonic Stem CellsHumansMass SpectrometryRetinal Pigment EpitheliumProteome

Identifiers

PMID28729539
PMCPMC5519552
OpenAlexW2735591967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.